发明名称 CONSERVED HBV AND HCV SEQUENCES USEFUL FOR GENE SILENCING
摘要 <p>PROBLEM TO BE SOLVED: To provide dsRNA-mediated gene silencing, utilizing compositions that provide at least a partial double-stranded dsRNA, which is expected to provide extremely valuable therapeutic and/or prophylactic agents against virus infection, including HBV and/or HCV, including the extremely difficult problem of chronic HBV and/or HCV infection.SOLUTION: The invention provides conserved consensus sequences derived from known hepatitis B virus and known hepatitis C virus strains, which are useful for inhibiting virus expression in mammalian cells. These sequences are useful for silencing HBV and HCV genes, thereby useful for treatment of HBV and HCV virus infections in humans.</p>
申请公布号 JP2015003913(A) 申请公布日期 2015.01.08
申请号 JP20140179056 申请日期 2014.09.03
申请人 ALNYLAM PHARMACEUTICALS INC 发明人 PACHUK CATHERINE;SATISHCHANDRAN CHANDRASEKHAR;ZURAWSKI VINCENT JR;MINTZ LIAT
分类号 A61K31/713;A61K35/76;A61P1/16;A61P31/20;C12N5/10;C12N15/09;C12N15/113 主分类号 A61K31/713
代理机构 代理人
主权项
地址